Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Jayamas Medica Industri Tbk's total inventories for the quarter that ended in Jun. 2026 was Rp735,800 Mil. PT Jayamas Medica Industri Tbk's average total inventories from the quarter that ended in Mar. 2026 to the quarter that ended in Jun. 2026 was Rp747,038 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. PT Jayamas Medica Industri Tbk's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was Rp53.55.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PT Jayamas Medica Industri Tbk's Days Inventory for the
three
months ended in Jun. 2026 was 178.84.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PT Jayamas Medica Industri Tbk's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.51.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Jayamas Medica Industri Tbk's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 1.26.
PT Jayamas Medica Industri Tbk (ISX:OMED) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
PT Jayamas Medica Industri Tbk's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Jayamas Medica Industri Tbk's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
PT Jayamas Medica Industri Tbk Total Inventories Related Terms
PT Jayamas Medica Industri Tbk Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Jayamas Medica Industri Tbk Total Inventories Chart
PT Jayamas Medica Industri Tbk Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of Rp735,800 Mil mean?
PT Jayamas Medica Industri Tbk (ISX:OMED) has a Total Inventories of Rp735,800 Mil as of Jun. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for PT Jayamas Medica Industri Tbk and its competitors.
Is PT Jayamas Medica Industri Tbk's Total Inventories too high?
PT Jayamas Medica Industri Tbk's current Total Inventories is Rp735,800 Mil. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's Total Inventories compare to ISRG and BDX?
PT Jayamas Medica Industri Tbk's Total Inventories of Rp735,800 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for PT Jayamas Medica Industri Tbk and its competitors. PT Jayamas Medica Industri Tbk's current Total Inventories is Rp735,800 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Fairly Valued. The stock's GF Value™ is Rp239.79, compared to a current price of Rp234.00 — trading 2.4% below its estimated fair value. The current Total Inventories is Rp735,800 Mil. PT Jayamas Medica Industri Tbk's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current Total Inventories is Rp735,800 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued.
The current stock price of Rp234.00 is trading 2.4% below its estimated GF Value™ of Rp239.79.
GuruFocus considers PT Jayamas Medica Industri Tbk to be Fairly Valued.
Key valuation signals for ISX:OMED:
Total Inventories: Rp735,800 Mil
GF Value™: Rp239.79 vs. price of Rp234.00 (2.4% below fair value)
No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
89GF Score
Get the complete analysis for ISX:OMED
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:OMED has been successfully added to your 
